Evidence map›Paper›PMID 39086878›Full record

ArticleJournal of the anus, rectum and colon2024

Surgical Management for Patients with Toxic Megacolon due to Ulcerative Colitis.

Toshifumi Watanabe, Daijiro Higashi, Hiroki Kaida, Hisatoshi Irie, Katsuzo Hanaoka, Jin Yamakado, Toshimitsu Maki, Yosuke Hirano, Hideki Nagano, Masato Watanabe

Abstract read
In one paragraph

Article in Journal of the anus, rectum and colon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Toshifumi WatanabeDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Daijiro HigashiDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Hiroki KaidaDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Hisatoshi IrieDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Katsuzo HanaokaDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Jin YamakadoDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Toshimitsu MakiDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Yosuke HiranoDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Hideki NaganoDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Masato WatanabeDepartment of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The present study reviewed cases of Toxic megacolon (TM) treated in our department, summarized the timing and technique of surgery, and considered key points for surgical management. Methods: This single-center retrospective study included the medical records of patients clinically diagnosed with TM who underwent surgery between 1985 and 2020. The diagnostic criteria and screening scores for sepsis, such as the systemic inflammatory response syndrome (SIRS) criteria, quick Sequential Organ Failure Assessment (qSOFA) score, and Modified Early Warning Score (MEWS), were validated. The preoperative clinical features and perioperative findings were also investigated. Results: There were eight male and six female patients. Nine patients (64.3%) satisfied the criteria for toxemia proposed by Narabayashi, and 10 patients (71.4%) fulfilled the SIRS criteria. A positive qSOFA score was confirmed in 1 patient (7.1%). The MEWS was high in 2 patients (14.3%). Intestinal perforation occurred in 2 patients (14.3%), and 1 of them died from disseminated intravascular coagulation. The mortality rate of TM with perforation was 50%. Eleven patients (78.6%) underwent total colectomy with end ileostomy. Conclusions: TM does not have well-defined diagnostic criteria, in addition to developing sometimes as borderline or fulminant cases, and must be recognized at an early stage, taking various findings into consideration. The criteria proposed by Narabayashi and the SIRS criteria, which met in a high percentage of our cases, are recommended as indicators for determining the toxicity of TM. It is also important to consider surgery in the early stages of TM, even if clinical findings do not meet all the criteria.

Indexed as

surgerytoxic megacolonulcerative colitis

Identifiers

PMID39086878
PMCPMC11286374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.